Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,031 public trials 2,028 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Active, Not Recruiting

Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas

NCT03478462

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +62 more
Locations
  • Lucile Packard Children's Hospital Palo Alto, California, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Duke University Chapel Hill, North Carolina, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View Trial Details
Active, Not Recruiting

A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants With Newly Diagnosed Multiple Myeloma

NCT05257083

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of Arkansas Little Rock, Arkansas, United States
  • City of Hope Duarte, California, United States
  • UC San Diego Health Moores Cancer Center San Diego, California, United States
  • University of California San Francisco (UCSF) San Francisco, California, United States
View all 106 locations
View Trial Details
Active, Not Recruiting

Front-line VenObi Combination Followed by Ven or VenZan Combination in Patients With Residual Disease: a MRD Tailored Treatment for Young Patients With High-risk CLL

NCT05478512

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • Ematologia AOU Careggi Florence, Italy
  • Ematologia IRST D.Amadori Meldola, Italy
  • Ematologia AO di Perugia Perugia, Italy
  • Ematologia Ospedale S.M. delle Croci Ravenna, Italy
View Trial Details
Active, Not Recruiting

Minimal Residual Disease-based Strategy With T-Cell Redirector After Treatment With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (D-VRd) in Newly Diagnosed Multiple Myeloma

NCT06353022

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • CH de la Côte Basque Bayonne, France
  • CHU Caen Caen, France
  • CHRU DIjon Dijon, France
  • Chd Vendee La Roche-sur-Yon, France
View all 19 locations
View Trial Details
Active, Not Recruiting

A Study of Nemtabrutinib vs Chemoimmunotherapy for Participants With Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Without TP53 Aberrations (MK-1026-008, BELLWAVE-008)

NCT05624554

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • Highlands Oncology Group ( Site 5205) Springdale, Arkansas, United States
  • Clermont Oncology Center ( Site 5224) Clermont, Florida, United States
  • Hattiesburg Clinic Hematology/Oncology ( Site 5216) Hattiesburg, Mississippi, United States
  • Medical Oncology Associates, PS ( Site 5206) Spokane, Washington, United States
View all 97 locations
View Trial Details
Active, Not Recruiting

Glofit and Obin in Follicular Lymphoma and Marginal Zone Lymphoma

NCT05783596

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Columbia University Irving Medical Center New York, United States
  • Mount Sinai Medical Center New York, United States
View Trial Details
Active, Not Recruiting

Catheter Ablation Versus Anti-arrhythmic Drugs for Ventricular Tachycardia

NCT05524077

Conditions
Aortic Stenosis, Subvalvular, Aortic Valve Disease, Aortic Valve Stenosis, +30 more
Locations
  • Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
  • Nepean Hospital Kingswood, New South Wales, Australia
  • John Hunter Hospital New Lambton Heights, New South Wales, Australia
  • Royal North Shore Hospital Saint Leonards, New South Wales, Australia
View Trial Details

Related conditions